KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) EPS (Basic): 2014-2024

Historic EPS (Basic) for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$0.47.

  • BeOne Medicines' EPS (Basic) rose 200.00% to $0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.05, marking a year-over-year increase of 107.96%. This contributed to the annual value of -$0.47 for FY2024, which is 27.69% up from last year.
  • As of FY2024, BeOne Medicines' EPS (Basic) stood at -$0.47, which was up 27.69% from -$0.65 recorded in FY2023.
  • BeOne Medicines' EPS (Basic)'s 5-year high stood at -$0.47 during FY2024, with a 5-year trough of -$1.50 in FY2020.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.65 (2023), whereas its average is -$0.87.
  • Per our database at Business Quant, BeOne Medicines' EPS (Basic) dropped by 23.14% in 2022 and then spiked by 56.38% in 2023.
  • Over the past 5 years, BeOne Medicines' EPS (Basic) (Yearly) stood at -$1.50 in 2020, then grew by 19.33% to -$1.21 in 2021, then declined by 23.14% to -$1.49 in 2022, then spiked by 56.38% to -$0.65 in 2023, then climbed by 27.69% to -$0.47 in 2024.